Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Investors excitement about the huge potential of novel AOMs propelled the valuations of Novo Nordisk and Lilly to record levels in 2024, with Lillys market cap reaching an all-time high of $912Bn on 30th August, the closest any biopharma company has come to the exclusive $1-trillion valuation
Final Thoughts on Retatrutide vs Semaglutide and Tirzepatide Retatrutide is not a GLP-3 drug
The information contained on this web site is provided for informational purposes only and is not intended to substitute for the advice provided by your doctor or other health care professional.
The results are inconsistent, the side effects are unpredictable, and the conclusions are unreliable
